Evidence map›Paper›PMID 27030720›Full record

ArticleMolecular pain2016

Involvement of NIPSNAP1, a neuropeptide nocistatin-interacting protein, in inflammatory pain.

Kazuya Okamoto, Masaki Ohashi, Kana Ohno, Arisa Takeuchi, Etsuko Matsuoka, Kyohei Fujisato, Toshiaki Minami, Seiji Ito, Emiko Okuda-Ashitaka

Open access · goldAbstract read
In one paragraph

Article in Molecular pain, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
0.2field-weighted citation impact, top 40% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 23 citations in OpenAlex.

  1. N6-methyladenosine readerWorld journal of gastroenterology · 2025
    Article
  2. Article
  3. Article
  4. NIPSNAP protein family emerges as a sensor of mitochondrial health.BioEssays : news and reviews in molecular, cellular and developmental biology · 2021
    Review
  5. Liver Expression ofAnimals : an open access journal from MDPI · 2020
    Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 1 country.

Kazuya OkamotoDepartment of Biomedical Engineering, Osaka Institute of Technology, Osaka, Japan.
Masaki OhashiDepartment of Biomedical Engineering, Osaka Institute of Technology, Osaka, Japan.
Kana OhnoDepartment of Biomedical Engineering, Osaka Institute of Technology, Osaka, Japan.
Arisa TakeuchiDepartment of Biomedical Engineering, Osaka Institute of Technology, Osaka, Japan.
Etsuko MatsuokaDepartment of Biomedical Engineering, Osaka Institute of Technology, Osaka, Japan.
Kyohei FujisatoDepartment of Biomedical Engineering, Osaka Institute of Technology, Osaka, Japan.
Toshiaki MinamiDepartment of Anesthesiology, Osaka Medical College, Takatsuki, Japan.
Seiji ItoDepartment of Medical Chemistry, Kansai Medical University, Hirakata, Japan.
Emiko Okuda-AshitakaDepartment of Biomedical Engineering, Osaka Institute of Technology, Osaka, Japan emiko.ashitaka@oit.ac.jp.
Osaka Institute of Technology · JPKansai Medical University · JPOsaka Medical and Pharmaceutical University · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundChronic pain associated with inflammation is an important clinical problem, and the underlying mechanisms remain poorly understood. 4-Nitrophenylphosphatase domain and nonneuronal SNAP25-like protein homolog (NIPSNAP) 1, an interacting protein with neuropeptide nocistatin, is implicated in the inhibition of tactile pain allodynia. Although nocistatin inhibits some inflammatory pain responses, whether NIPSNAP1 affects inflammatory pain appears to be unclear. Here, we examined the nociceptive behavioral response of NIPSNAP1-deficient mice and the expression of NIPSNAP1 following peripheral inflammation to determine the contribution of NIPSNAP1 to inflammatory pain.

resultsNociceptive behavioral response increased in phase II of the formalin test, particularly during the later stage (26-50 min) in NIPSNAP1-deficient mice, although the response during phase I (0-15 min) was not significantly different between the deficient and wild-type mice. Moreover, phosphorylation of extracellular signal-related kinase was enhanced in the spinal dorsal horn of the deficient mice. The prolonged inflammatory pain induced by carrageenan and complete Freund's adjuvant was exacerbated in NIPSNAP1-deficient mice. NIPSNAP1 mRNA was expressed in small- and medium-sized neurons of the dorsal root ganglion and motor neurons of the spinal cord. In the formalin test, NIPSNAP1 mRNA was slightly increased in dorsal root ganglion but not in the spinal cord. In contrast, NIPSNAP1 mRNA levels in dorsal root ganglion were significantly decreased during 24-48 h after carrageenan injection. Prostaglandin E2, a major mediator of inflammation, stimulated NIPSNAP1 mRNA expression via the cAMP-protein kinase A signaling pathway in isolated dorsal root ganglion cells.

conclusionsThese results suggest that changes in NIPSNAP1 expression may contribute to the pathogenesis of inflammatory pain.

Indexed as

AnimalsCyclooxygenase InhibitorsDinoprostoneFormaldehydeGanglia, SpinalInflammationIntercellular Signaling Peptides and ProteinsMembrane ProteinsMiceNeuropeptidesOpioid PeptidesPainProteinsRNA, MessengerCyclooxygenase InhibitorsDinoprostoneFormaldehydeIntercellular Signaling Peptides and ProteinsMembrane ProteinsNeuropeptidesNipsnap1 protein, mousenocistatinOpioid PeptidesProteinsRNA, Messengergene expressioninflammatory painNIPSNAP1prostaglandin E2

Identifiers

PMID27030720
PMCPMC4956003
OpenAlexW2339998946

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.